FDA Expands approval of 21-valent pneumococcal vaccine Capvaxive for High-Risk Children Written By Dr. Kamal Kant Kohli19 Jun 2026 9:00 PM ISTThe U.S. FDA has expanded the approval of Merck's 21-valent pneumococcal vaccine, Capvaxive, to include children who are at increased risk for...
Merck's CAPVAXIVE Gets USFDA Nod for Children, Adolescents at Increased Pneumococcal Disease Risk Written By Farhat Nasim19 Jun 2026 10:00 AM ISTNew Delhi: Global biopharmaceutical company Merck has announced that the U.S. Food and Drug Administration (USFDA) has approved an expanded indication...
Pfizer's Experimental Pneumococcal Vaccine Shows Stronger Immune Response Than Prevnar 20 Written By sheeba farhat20 May 2026 11:35 PM ISTBengaluru: Pfizer said on Wednesday its experimental pneumococcal vaccine showed ​significantly stronger immune response ​than its current shot,...
NPPA Defers Price Exemption for Biological E's Pneumonia Vaccine, Seeks Patent Clarifications Written By Susmita Roy19 April 2026 1:11 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has deferred its decision on granting exemption under Para 32 (i, ii & iii) of the...
Pneumococcal Vaccination in Hematological Malignancies (HM)-Indian Hematology Expert Consensus 2025 Written By Dr. Kamal Kant Kohli30 Sept 2025 12:40 PM ISTPneumococcal vaccination is strongly recommended for patients with specific hematological malignancies, a recently released Indian hematology expert...
Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases Written By Dr. Sanjay Mittal14 May 2025 11:37 AM ISTCardiovascular diseases (CVD) account for 24.8% of all deaths in India, with an age-standardized death rate of 272 per 100,000-higher than the global...
Merck Capvaxive gets European Commission nod for prevention of Invasive Pneumococcal Disease, Pneumococcal Pneumonia in adults Written By Ruchika Sharma27 March 2025 12:15 PM ISTEuropean Commission (EC) Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and...
Addressing Pneumococcal Disease in CKD Patients: A Call for Preventive Action Dr. Alan Almeida22 Jan 2025 11:49 AM ISTIn India, the prevalence of chronic kidney disease (CKD) has reached epidemic proportions, with population-based studies reporting a prevalence...
Pfizer Gets CDSCO Panel Nod To Import 20 Valent Pneumococcal Conjugate Vaccine Written By Dr. Divya Colin7 Dec 2024 5:45 PM ISTNew Delhi: Pfizer has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to...
Revolutionizing COPD Care: The Role Of Pneumococcal Vaccines in Enhancing Patient Outcomes Dr Rajesh V11 Oct 2024 12:00 PM ISTExacerbations are recognized to be crucial acute events that are associated with increased hospitalization rates and worsening clinical outcomes. Both...
Submit Immunogenicity Data: CDSCO Panel Tells Pfizer on Pneumococcal Polysaccharide Conjugate Vaccine study Written By Dr. Divya Colin12 Aug 2024 6:00 PM ISTNew Delhi: Reviewing the Phase III clinical trial report of the 20 valent Pneumococcal Conjugate Vaccine (20vPnC) presented by Pfizer, the Subject...
Navigating Pneumococcal Health: Insights Into Pneumococcal Conjugate Vaccination - Dr Pradeep Bajad Written By Dr Pradeep Bajad15 April 2024 4:27 PM IST Pneumococcal disease in vaccinated individuals and in the population. Pneumococcal vaccination is indicated for adults with risk factors for...
